COVID-19 Vaccination Planning

Last Updated: November 6, 2020

Download PDF

This Briefing Note was completed by the Research, Analysis, and Evaluation Branch (Ministry of Health) in collaboration with a member of the COVID-19 Evidence Synthesis Network. Please refer to the Methods section for further information.


This note provides a summary of planning approaches for vaccinating populations for COVID-19.

*The full version of the Briefing Note including Supporting Evidence and the Appendix can be accessed in the PDF file at the top of the page*

Key Findings

Implementation Implications

Integrated vaccine responses are required within and across jurisdictions. Detailed scenarios should be planned for now based on prior vaccination campaigns and current COVID-19 research, but they may evolve as more information becomes available.

Supporting Evidence

*The entirety of the Supporting Evidence section can be accessed in the PDF file located at the top of the page*

This section summarizes the scientific evidence and jurisdictional experiences regarding plans for vaccinating populations against COVID-19 in terms of: supply, allocation, ordering, distribution, inventory management, administration, and performance indicators. Jurisdictions reviewed include: Canada, Australia, France, Germany, Japan, Mexico, New Zealand, South Africa, Spain, United Kingdom (UK), and United States (US), as well as the World Health Organization (WHO) and European Commission.


The COVID-19 Evidence Synthesis Network is comprised of groups specializing in evidence synthesis and knowledge translation. The group has committed to provide their expertise to provide high-quality, relevant, and timely synthesized research evidence about COVID-19 to inform decision-makers as the pandemic continues. The following member of the Network provided an evidence synthesis product that was used to develop this Evidence Synthesis Briefing Note: